Industry updates with Dusko Ilic: July 2023

Written by Dusko ILIC
Cell therapy Clinical trials Cord blood FDA Gene therapy Industry developments Report

Read highlights from the July installment of Dusko Ilic’s industry news, which discusses the latest developments and news in regenerative medicine and stem cell research, and is published every month in Regenerative Medicine. Every month, Dusko comments on regenerative medicine industry news of note. Read the full update for July 2023 in Regenerative Medicine here >>> Find previous updates here>>> What happened this month that you were expecting? There is always a niche for cell therapy business MyoPax (Berlin, Germany), a company specializing in regenerative cell therapy, has recently received two important designations Rare Pediatric Disease Designation and Orphan Drug...

To view this content, please register now for access

It's completely free